Patent · US Active

Synthesis, polymorphs, and pharmaceutical formulation of FAAH inhibitors

US7888394B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignee

N.V.Organon · NL

Inventors

David Putman · Irvine, US
Olivier Dasse · Lake Forest, US

Key dates

Filing date	Aug 16, 2007
Grant date	Feb 15, 2011
Priority date	—
Expiry date	Oct 20, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C269/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. The alkylcarbamic acid aryl ester of Formula (I), KDS-4103, is a FAAH inhibitor. Described herein is a process for the preparation of the compound of Formula (I), characterization of polymorphs of the FAAH inhibitor, and their uses therof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.